NCT06506422View on ClinicalTrials.gov

Empagliflozin Reversal of Arterial StiffnEss in Aging

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 18, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

February 28, 2029

Conditions
AgingArterial Stiffness
Interventions
DRUG

Empagliflozin 10 MG

10mg Empagliflozin daily for 12 weeks

DRUG

Placebo

10mg Placebo daily for 12 weeks

Trial Locations (1)

65211

RECRUITING

University of Missouri, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER